Publications
Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.
Abuga KM. et al, (2027), Lancet Glob Health
Cellular immunity to Streptococcus pneumoniae: implications for vaccine-mediated prevention.
VanSeggelen H. et al, (2026), Expert Rev Vaccines, 25
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Firth C. et al, (2026), Hum Vaccin Immunother, 22
Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Monk V. et al, (2026), Expert Rev Vaccines, 25
The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.
Kazungu Y. et al, (2026), Virulence, 17
What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty
Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13
Timing matters: Exon skipping therapy is most effective when initiated early in a mouse model of Duchenne muscular dystrophy.
Stenler S. et al, (2026), Mol Ther Nucleic Acids, 37
Accurately modeling RNase H-mediated antisense oligonucleotide efficacy.
Hill B. et al, (2026), Mol Ther Nucleic Acids, 37
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.
Prunotto G. et al, (2026), J Hum Immun, 2
High respiratory syncytial virus burden in children under 3 years of age across all care levels in England.
Carter EC. et al, (2026), BMJ Open Respir Res, 13
Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.
Palmer JM. et al, (2026), Blood
Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro.
Nazki S. et al, (2026), Virology, 624